Thompson Siegel & Walmsley LLC Bio Rad Laboratories, Inc. Transaction History
Thompson Siegel & Walmsley LLC
- $6.43 Billion
- Q4 2024
A detailed history of Thompson Siegel & Walmsley LLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Thompson Siegel & Walmsley LLC holds 258,153 shares of BIO stock, worth $71.6 Million. This represents 1.32% of its overall portfolio holdings.
Number of Shares
258,153
Previous 306,793
15.85%
Holding current value
$71.6 Million
Previous $103 Million
17.38%
% of portfolio
1.32%
Previous 1.53%
Shares
15 transactions
Others Institutions Holding BIO
# of Institutions
478Shares Held
19.2MCall Options Held
15.7KPut Options Held
11.5K-
Vanguard Group Inc Valley Forge, PA1.92MShares$532 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$430 Million0.01% of portfolio
-
Wealthfront Advisers LLC1.04MShares$289 Million0.29% of portfolio
-
Veritas Asset Management LLP977KShares$271 Million3.36% of portfolio
-
Dimensional Fund Advisors LP Austin, TX746KShares$207 Million0.06% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $6.83B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...